Report Detail

Medical Devices & Consumables Pavmed Inc (PAVM) - Product Pipeline Analysis, 2018 Update

  • RnM2733825
  • |
  • 07 January, 2019
  • |
  • Global
  • |
  • 34 Pages
  • |
  • GlobalData
  • |
  • Medical Devices & Consumables

Summary

Pavmed Inc (Pavmed) is a medical device company. The company offers disposable infusion pumps, short-term catheters, percutaneous and tissue ablation devices, and long-term vascular access devices. Its products pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Pavmed’s product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company has operations throughout the US. Pavmed is headquartered in New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Pavmed Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company


Table of Contents

    Table of Contents 2

      List of Tables 3

        List of Figures 3

          Pavmed Inc Company Overview 4

            Pavmed Inc Company Snapshot 4

              Pavmed Inc Pipeline Products and Ongoing Clinical Trials Overview 4

                Pavmed Inc – Pipeline Analysis Overview 7

                  Pavmed Inc - Key Facts 7

                    Pavmed Inc - Major Products and Services 8

                      Pavmed Inc Pipeline Products by Development Stage 9

                        Pavmed Inc Pipeline Products Overview 11

                          Caldus - Renal Denervation 11

                            Caldus - Renal Denervation Product Overview 11

                              Caldus - Traditional Tissue Ablation 12

                                Caldus - Traditional Tissue Ablation Product Overview 12

                                  CarpX 13

                                    CarpX Product Overview 13

                                      DisappEAR 14

                                        DisappEAR Product Overview 14

                                          NextCath 15

                                            NextCath Product Overview 15

                                              NextFlo 16

                                                NextFlo Product Overview 16

                                                  PortIO 17

                                                    PortIO Product Overview 17

                                                      PortIO Device - Next Generation 18

                                                        PortIO Device - Next Generation Product Overview 18

                                                          Pavmed Inc - Key Competitors 19

                                                            Pavmed Inc - Key Employees 20

                                                              Pavmed Inc - Locations And Subsidiaries 21

                                                                Head Office 21

                                                                  Recent Developments 22

                                                                    Pavmed Inc, Recent Developments 22

                                                                      Jul 11, 2018: PAVmed Appoints Shaun O’Neil Chief Commercial Officer 22

                                                                        Jul 09, 2018: Nasdaq Notifies PAVmed of Regained Compliance with Continued Listing Requirements 22

                                                                          Jun 27, 2018: PAVmed Provides Business Update 23

                                                                            May 22, 2018: PAVmed Announces First Quarter 2018 Financial Results 24

                                                                              Dec 18, 2017: Fierce Innovation Awards 2017 Recognizes PAVmeds CarpX Device for Technology Innovation 25

                                                                                Nov 28, 2017: Pavmed Files 510(K) Submission With FDA for Carpx Device to Treat Carpal Tunnel Syndrome 26

                                                                                  Nov 15, 2017: PAVmed Reports Third Quarter 2017 Financial Results 27

                                                                                    Aug 14, 2017: PAVmed Reports Second Quarter 2017 Financial Results 28

                                                                                      May 22, 2017: PAVmed Reports First Quarter 2017 Financial Results and Provides Business Update 29

                                                                                        May 10, 2017: PAVmed to Hold Business Update Conference Call on May 17th 30

                                                                                          Appendix 31

                                                                                            Methodology 31

                                                                                              About GlobalData 34

                                                                                                Contact Us 34

                                                                                                  Disclaimer 34

                                                                                                  Summary:
                                                                                                  Get latest Market Research Reports on Pavmed Inc (PAVM) . Industry analysis & Market Report on Pavmed Inc (PAVM) is a syndicated market report, published as Pavmed Inc (PAVM) - Product Pipeline Analysis, 2018 Update. It is complete Research Study and Industry Analysis of Pavmed Inc (PAVM) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                                  Last updated on

                                                                                                  REPORT YOU MIGHT BE INTERESTED

                                                                                                  Purchase this Report

                                                                                                  $750.00
                                                                                                  $1,500.00
                                                                                                  $2,250.00
                                                                                                  599.25
                                                                                                  1,198.50
                                                                                                  1,797.75
                                                                                                  699.75
                                                                                                  1,399.50
                                                                                                  2,099.25
                                                                                                  116,662.50
                                                                                                  233,325.00
                                                                                                  349,987.50
                                                                                                  62,497.50
                                                                                                  124,995.00
                                                                                                  187,492.50
                                                                                                  Credit card Logo

                                                                                                  Related Reports


                                                                                                  Reason to Buy

                                                                                                  Request for Sample of this report